--- title: "ASURAGEN INCORPORATED — Capability Statement" uei: "E8M9NXN4X4Y7" cage: "4GGP6" canonical: "https://teamingindex.com/contractor/E8M9NXN4X4Y7/capability.md" html_url: "https://teamingindex.com/contractor/E8M9NXN4X4Y7" updated: "2026-11-09T17:28:18.052Z" generator: "TeamingIndex capability twin 1.0" legal_name: "ASURAGEN INCORPORATED" primary_naics: "325413" sam_status: "expiring" active_exclusion: false claimed: false tier: "unclaimed" --- # ASURAGEN INCORPORATED > ASURAGEN INCORPORATED is a SAM.gov-registered entity based in AUSTIN, TX 78744-1038. UEI E8M9NXN4X4Y7; CAGE 4GGP6; primary NAICS 325413. Compliance posture not provided. SAM registration expires in 54 days. > **Unclaimed profile:** seeded from SAM.gov and USAspending public records. The entity has not claimed it, so capabilities and compliance posture have not been provided. ## Identifiers - **Legal business name:** ASURAGEN INCORPORATED - **UEI (SAM.gov Unique Entity ID):** E8M9NXN4X4Y7 - **CAGE code:** 4GGP6 - **Entity structure:** Corporate Entity (Not Tax Exempt) - **State of incorporation:** DE - **Website:** - **TeamingIndex profile:** - **Profile status:** Unclaimed · seeded from SAM.gov and USAspending public records ## Location - **Physical address (city, state, ZIP):** AUSTIN, TX 78744-1038 - **Country:** United States - **Congressional district:** TX-35 ## NAICS & PSC | NAICS | Title | Primary | Small under SBA size standard (SAM.gov) | | --- | --- | --- | --- | | 325413 | — | Yes | No | | 325414 | Biological Product (except Diagnostic) Manufacturing | No | No | | 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | No | No | | 621511 | Medical Laboratories | No | No | | PSC | Name | | --- | --- | | 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | | AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | | H165 | QUALITY CONTROL- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | - **PSC names:** Acquisition.gov PSC Manual (April 2025 edition) Size status is NAICS-specific and reflects the entity’s SAM.gov representations; check it against the size standard of the solicitation’s NAICS code. ## Socio-economic status No socio-economic designations reported in SAM.gov. Source: SAM.gov entity registration, synced 2026-11-09. Confirm current SBA certification (8(a), HUBZone, WOSB/EDWOSB, VetCert SDVOSB/VOSB) before relying on a status for a set-aside. ## SAM registration & exclusion screening - **Registration:** SAM registration expires in 54 days - **Registration expires:** 2027-01-07 - **Registration activated:** 2026-01-09 - **Exclusion screening (FAR subpart 9.4):** No active exclusion recorded in SAM.gov - **Teaming eligibility:** Eligible to be proposed as a team member (active registration, no exclusion) - **Source:** SAM.gov Entity Management, synced 2026-11-09 ## Compliance posture Compliance posture not provided by the contractor. - Facility clearance: visible to paid members - Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). ## Contract vehicles No contract vehicle holdings on file. ## Past performance - **Total obligated, trailing 36 months (USAspending.gov):** $552,493 - **Award history:** 1 award on record - **Top funding agencies:** Department of the Army Showing the 1 award on record. | Award PIID | Agency | NAICS / PSC | Obligated | Base + all options | Period of performance | Set-aside | Place of performance | Description | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | W81K0022P0237 | Department of Defense / Department of the Army | 325413 / 6515 | $552,493 | — | 2022-10-01 → 2027-09-30 | — | TX | QUANTIDEX QPCR BCR ABL IS KIT REAGENTS AND QUANTIDEX QPCR BCR-ABL MINOR KIT REAGENTS. | ## Proven teaming graph - No first-tier sub-award reports name this company yet - Source: USAspending.gov sub-award reports (FSRS), sync date not recorded. Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values. ## SBIR/STTR portfolio - SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects - 23 SBIR/STTR awards totaling $12.4M: SBIR Phase I 17, SBIR Phase II 6 - By agency: Department of Health and Human Services 23 - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2019, Sep 30, 2019 to Aug 31, 2020: Novel Strategies for Development of a Multiplexed Test with Expanded Content for Spinal Muscular Atrophy ($182,393) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2019, Sep 20, 2019 to Aug 31, 2020: Novel Strategies for Enhanced Detection of Hemoglobinopathy Carriers ($231,153) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2019, Sep 15, 2019 to Sep 14, 2020: AmplideX DeepNet, a new paradigm for deep learning analytical tools in the molecular diagnostic space ($223,058) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2019, Jun 7, 2019 to May 31, 2020: Single cell prenatal testing of circulating trophoblasts using a the novel immunomagnetic Micro-Aperture Chip (IMAC) system ($196,910) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2019, May 15, 2019 to Apr 30, 2020: A single test utilizing a unified multiplex PCR/CE workflow targeting five dominant inherited ataxias ($181,033) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2018, Sep 1, 2018 to Aug 31, 2019: Novel strategies for enhanced analysis of repeat disorders ($224,999) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2018, Apr 1, 2018 to Mar 31, 2020: Improving rare variant detection in next generation sequencing of liquid biopsies with a molecular barcoding technique that combines a novel primer structure and sophisticated bioinformatics methods ($224,999) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2018, Apr 1, 2018 to Mar 31, 2020: Development of a unified information-rich test for CNBP and DMPK to improve assessment of Myotonic Dystrophy Type 1 and 2 ($224,978) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2017, Apr 15, 2017 to Sep 30, 2019: Development of a unified Alzheimer s disease test that combines high resolution analysis of TOMM and Apolipoprotein E for improved risk estimates ($224,984) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2016, Sep 30, 2016 to Aug 31, 2019: Development of an information rich assay for C ORF as a test for ALS and FTD ($1,379,750) - Phase III: Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual. - Source: SBIR.gov award data file, as of Nov 12, 2026 (file published Nov 1, 2026) ## FedRAMP offerings - No FedRAMP Marketplace listing is linked to this company - Source: FedRAMP Marketplace, sync date not recorded ## Exclusions & screening - No active SAM.gov exclusion on record (checked Nov 14, 2026) - Source: SAM.gov Exclusions, as of Nov 14, 2026 - No confirmed match on the Consolidated Screening List (screened Nov 14, 2026) ## Contract vehicles on federal record - No contract-vehicle seats on federal record are linked to this company ## GSA CALC+ rates - No GSA CALC+ awarded ceiling rates on record for this company - Source: GSA CALC+ awarded ceiling rates, sync date not recorded. Ceiling rates are the most an agency can be charged, not prices paid ## Capabilities & differentiators No capability narrative published. ## Technical tags No technical tags published. ## Teaming preferences - Teaming preferences not published - **Teaming requests and NDAs:** request an introduction on the TeamingIndex profile (sign-in required): ## Business development contact No business-development contact published. ## Corporate hierarchy - No parent entity reported in SAM.gov - Affiliation with a parent or sister concerns can affect small-business size status (13 CFR 121.103). ## Provenance & disclaimer - **SAM.gov entity registration** (identifiers, NAICS/PSC, size and socio-economic status, hierarchy, registration and exclusion status): synced 2026-11-09 - **USAspending.gov** (prime award history and trailing 36-month obligations): nightly sync - **Contractor-provided profile** (capabilities, teaming preferences, self-attested compliance): not provided - **TeamingIndex verification** (credentials marked “Verified by TeamingIndex”): no verified credentials on record; methodology: - **Blind SPRS:** exact NIST SP 800-171 SPRS scores are published only when the contractor opts in; brackets are cumulative thresholds (SPRS ≥ 0, SPRS ≥ 50, SPRS ≥ 70, SPRS ≥ 85, SPRS ≥ 95, SPRS ≥ 105, SPRS = 110 (perfect)). - **Before award:** self-attested facts have not been independently verified. Confirm registration and exclusions in SAM.gov, CMMC status and SPRS assessment currency with the contractor (DFARS 252.204-7019, -7020 and -7021), facility clearances through DCSA’s NISS, AS9100-series certificates in the IAQG OASIS database, and FedRAMP authorizations on the FedRAMP Marketplace. - **Zero CUI:** this document contains no Controlled Unclassified Information. TeamingIndex stores verification metadata only, never SSPs, POA&Ms or DD Form 254s. - **Machine-readable:** schema.org JSON-LD is embedded in ; this twin: ; site index: © 2026 HILARTECH, LLC. All rights reserved. TeamingIndex.com is an independent defense industrial base intelligence platform owned and operated by HILARTECH, LLC and is not affiliated with or endorsed by the U.S. Department of Defense (DoD), the General Services Administration (GSA), or SAM.gov.